Real-World CML treatment patterns revealed in large U.S. study
NCT ID NCT07374120
First seen Feb 01, 2026 · Last updated May 16, 2026 · Updated 11 times
Summary
This study reviewed medical records of 1,480 adults with chronic-phase chronic myeloid leukemia (CML-CP) treated in U.S. community oncology clinics between 2016 and 2022. Researchers looked at which drugs were used, how doses were adjusted, and how well patients responded to treatment. The goal was to understand real-world treatment patterns and outcomes outside of clinical trials.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LEUKEMIA, MYELOID, CHRONIC-PHASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Novartis
East Hanover, New Jersey, 07936, United States
Conditions
Explore the condition pages connected to this study.